Armistice Capital's re-accumulation to a 9.79% stake signals renewed conviction after a prior exit. Monitor for any subsequent 13D conversion or engagement with management, though the filing certifies passive intent.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1- T+0 · Nov 16 $4.42entry
- T+1 · 15h ago +0.45%α +1.47% · $4.44
- T+5 · in 5d Pending
- T+20 · in 27d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Armistice Capital filed a new Schedule 13G disclosing a 9.79% passive stake in Treace Medical Concepts as of September 30, 2026, up from 1.96% in its prior filing. This marks a significant re-accumulation by a former top holder after reducing below 5% earlier in the year.
Key Financial Metrics
Key Facts
- Armistice Capital disclosed beneficial ownership of 6,364,000 shares of Treace Medical Concepts common stock.
- The stake represents 9.79% of shares outstanding as of September 30, 2026.
- This is a new Schedule 13G filing, not an amendment, indicating a new 5%+ position.
- The filing certifies passive intent under Rule 13d-1(b), with no control influence purpose.
- Armistice Capital's prior 13G/A (filed same day) showed a 1.96% stake, meaning the fund crossed back above 5% between September 30 and the filing date.
Financial Impact
9.79% stake valued at approximately $34.3M based on $350M market cap.
Risk Factors
- A 9.79% holder could potentially influence shareholder votes or seek board representation despite passive certification.
- The fund's rapid stake change (from below 5% to 9.79%) may attract SEC or market scrutiny.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0001172661-26-005301 |
| Document: 0001172661-26-005301-index.html | 0001172661-26-005301 |
| Document: 0001172661-26-005301.txt | 0001172661-26-005301 |
Track record
11 reports on TMCI
2 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +12.39% at T+60 after the Jul 13, 2026 report. 2 of 3 went positive at some point.
Filters
- Nov 16, 20261d ago SC 13G Neutral 4/10 Viewing Entry $4.42 to $4.44 Now $4.44 +0.45% ▲ +0.45% +1.47% vs SPY
- Nov 16, 20261d ago SC 13G/A Bearish 4/10 Entry $4.42 to $4.44 Now $4.44 −0.45% ▼ −0.45% −1.47% vs SPY
- Nov 12, 20266d ago Court Ruling Neutral 4/10 Entry $5.27 to $4.42 Now $4.44 −15.75% ▼ −16.13% −14.22% vs SPY
- Nov 6, 202611d ago 8-K Neutral 4/10 Entry $4.03 to $4.78 Now $4.44 +10.17% ▲ +18.61% +16.24% vs SPY
- Sep 17, 20268w ago Press Release Neutral 4/10 Entry $4.49 to $4.48 Now $4.44 −1.11% ▼ −0.22% −1.77% vs SPY
- Aug 7, 202614w ago 8-K Mixed 6/10 Entry $4.76 to $4.67 Now $4.44 −6.72% ▼ −1.89% −1.86% vs SPY
- Jul 13, 202618w ago Court Ruling Bearish 5/10 Entry $4.44 to $4.40 Now $4.44 −0.00% ▲ +0.90% +1.30% vs SPY
- May 8, 202627w ago Press Release Bearish 7/10 Entry $2.01 to $1.94 Now $4.44 −120.90% ▲ +3.48% +3.71% vs SPY
- Apr 24, 202629w ago Press Release Neutral 1/10 Entry $1.98 to $1.92 Now $4.44 +124.24% ▼ −3.03% −3.19% vs SPY
- Apr 9, 202631w ago 8-K Mixed 6/10 Entry $1.53 to $1.81 Now $4.44 +190.20% ▲ +18.30% +18.36% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers